Rorarix (GSK) is the only rotavirus vaccine available in New Zealand. It has been used in other parts of the world since 2005.
Rotavirus vaccine is very effective against severe rotavirus gastroenteritis with the vaccine preventing around half of all hospital admissions for all cause acute gastroenteritis in the clinical trials. Efficacy against severe rotavirus gastroenteritis is around 85 - 100%.
Monovalent human G1 rotavirus vaccine (Rotarix ®, GSK)
Disclaimer: This site is intended to be flexible and frequently updated. While every effort has been made to ensure accuracy, all information should be verified.